| In Silico Strategies in Tuberculosis Drug Discovery SJY Macalino, JB Billones, VG Organo, MCO Carrillo Molecules 25 (3), 665, 2020 | 70 | 2020 |
| Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosisl,d-transpeptidase 2 JB Billones, MCO Carrillo, VG Organo, SJY Macalino, JBA Sy, ... Drug design, development and therapy, 1147-1157, 2016 | 34 | 2016 |
| In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA) JB Billones, MCO Carrillo, VG Organo, JBA Sy, NAB Clavio, SJY Macalino, ... Drug design, development and therapy, 563-574, 2017 | 23 | 2017 |
| In ovo and in silico evaluation of the anti-angiogenic potential of syringin CA Aventurado, JB Billones, RD Vasquez, AL Castillo Drug Design, Development and Therapy, 5189-5204, 2020 | 15 | 2020 |
| In silico analysis of binding interactions between GSK983 and human DHODH through docking and molecular dynamics MJA Bernaldez, JB Billones, A Magpantay AIP Conference Proceedings 2045 (1), 2018 | 13 | 2018 |
| Virtual screening of natural products, molecular docking and dynamics simulations on M. tuberculosis S-adenosyl-L-homocysteine hydrolase ARBS Iii, JB Billones Orient J Chem 31, 1859-1865, 2015 | 12 | 2015 |
| Virtual Screening against Mycobacterium tuberculosis Lipoate Protein Ligase B (MtbLipB) and In Silico ADMET Evaluation of Top Hits JB BILLONES, MCO CARRILLO, VG ORGANO, SJOYY MACALINO, ... | 12 | 2013 |
| Towards antituberculosis drugs: molecular docking of curcumin and its analogues to pantothenate synthetase CTM Yang, JB Billones Phil J Sci 141 (2), 187-196, 2012 | 11 | 2012 |
| Towards antituberculosis drugs: virtual screening for potential inhibitors of pantothenate synthetase of Mycobacterium tuberculosis VCC Uy, JB Billones Phil Sci Lett 5 (2), 122-130, 2012 | 11 | 2012 |
| Structure-based discovery of inhibitors against MurE in methicillin-resistant Staphylococcus aureus JB Billones, MAT Bangalan Oriental Journal of Chemistry 35 (2), 618, 2019 | 10 | 2019 |
| Reverse docking study unravels the potential Mycobacterium tuberculosis enzyme targets of Agelasine F JB Billones Orient J Chem 32 (2), 851-858, 2016 | 10 | 2016 |
| Structure-Based Design of Inhibitors Against Maltosyltransferase GlgE JB Billones, AMF Valle Oriental Journal of Chemistry 30 (3), 1137-1145, 2014 | 10 | 2014 |
| Virtual screening against M. tuberculosis 7, 8-diaminopelargonic acid synthase (MtbBioA) and in silico toxicity evaluation of top hits J Billones, MC Carrillo, V Organo, S J. Macalino, I Emnacen, J B. Sy Current Enzyme Inhibition 10 (2), 105-112, 2014 | 5 | 2014 |
| A univariate analysis of molecular properties and inhibitory activity of dihydrothiophenones against dihydroorotate dehydrogenase of malaria parasite L Billones, J Billones Journal of Chemical and Pharmaceutical Research 6 (8), 209-217, 2014 | 5 | 2014 |
| QSAR Study of Cyclooxygenase-2 (COX-2) Inhibitors JB Billones, SM Buenaobra Philippine Journal of Science 140 (2), 125-132, 2011 | 5 | 2011 |
| Preliminary characterization and in silico studies on the alpha-amylase inhibitors from Momordica charantia AMP06 methanolic leaf extract AB Asejo, PG Moreno, J Billones, R Nacario, FMH III Philippine Journal of Biochemistry and Molecular Biology 1 (1), 61-70, 2020 | 4 | 2020 |
| Piggyback drug development: Molecular docking of Entacapone analogues as direct M. tuberculosis InhA inhibitors DL Cordova, RJ Abuel, M Galingana, L Villanueva, J Billones Journal of Chemical and Pharmaceutical Research 7 (5), 636-642, 2015 | 4 | 2015 |
| Virtual screening against Mycobacterium tuberculosis isocitrate lyase and in silico ADME-Tox evaluation of top hits NAB Clavio, JB Billones J Chem Pharm Res 6 (10), 727-738, 2014 | 4 | 2014 |
| Computational Studies of Dipyridodiazepinones as Human Immunodeficiency Virus (HIV) Reverse Transcriptase Inhibitors RG Villavicencio, JB Billones Philippine Journal of Science 138 (1), 105-113, 2009 | 4 | 2009 |
| Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation HC Alos, JB Billones, AL Castillo, RD Vasquez DARU Journal of Pharmaceutical Sciences 30 (2), 273-288, 2022 | 3 | 2022 |
Graham HeathAssociate Professor and Reader, UNSW Canberra
